China has unveiled a comprehensive roadmap to accelerate the high-quality development of sci-tech insurance, aiming to align financial support with the country's technological innovation ambitions. The guidelines, jointly issued by the Ministry of Science and Technology, the National Financial Regulatory Administration, the Ministry of Industry and Information Technology, and the China National Intellectual Property Administration, outline 20 measures across six focus areas.

Sci-tech insurance in China covers a wide spectrum of innovation-related risks, including R&D expenditure losses, commercialization setbacks, application and promotion risks, and intellectual property infringement. Beyond providing a safety net, it functions as a stabilizing force for innovation, helping to absorb the high costs and extended cycles intrinsic to research and development. In 2025 alone, coverage reached approximately 8 trillion yuan (≈1.16 trillion U.S. dollars), with premiums rising 44 percent year on year, underscoring both rapid market growth and rising demand.

The new guidelines emphasize three key priorities for the sector:

1. Supporting major technological breakthroughs and strategic initiatives – Risk-sharing mechanisms will be enhanced, and insurance services for key national technology forces and strategic regions will be strengthened.

2. Empowering tech-focused SMEs – Insurers are encouraged to develop simpler, more affordable products with streamlined subscription and claims processes, expanding coverage for smaller enterprises whose innovation activities are often higher-risk but economically vital.

3. Promoting innovation across the insurance ecosystem – The measures call for specialized product development, refined actuarial pricing, professionalized underwriting and claims services, and targeted support for intellectual property, cybersecurity, and talent-focused insurance solutions.

In addition to risk coverage, the guidelines also channel long-term insurance capital toward technological innovation, supporting investment in emerging and future industries, major national tech projects, and venture capital initiatives. This dual role—mitigating risk while mobilizing patient capital—positions sci-tech insurance as a cornerstone for sustainable innovation finance.

For investors and financial professionals, China's roadmap signals an expanding, high-potential market where insurance is not just protection but a strategic enabler of innovation. By integrating risk management with investment flows, the country is fostering an ecosystem in which technological advancement and financial innovation reinforce one another—offering opportunities for domestic and international stakeholders to participate in a sector poised for robust growth.